Boehringer Ingelheim GmbH and Eli Lilly and Company (LLY) Alliance to Feature 34 Presentations in Type 1 and Type 2 Diabetes at the 73rd American Diabetes Association Scientific Sessions®
6/11/2013 6:53:52 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Ex US & UK Medical Media Only
Boehringer Ingelheim and Eli Lilly and Company are pleased to announce that the companies’ diabetes alliance will have a strong scientific and clinical presence at the 73rd American Diabetes Association (ADA) Scientific Sessions® in Chicago, 21–25 June, with 34 posters, abstracts and an oral presentation.
Help employers find you! Check out all the jobs and post your resume.